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Summary of main achievements and outcomes; The earthworm Eisenia veneta was successfully 
exposed to various metal based nanoparticles (NP). Exposures were undertaken in vivo of individual 
earthworms in aqueous and soil media, and in vitro of extracted immune cells in physiological 
saline. Exposures were conducted to ZnO nanopowder (Sigma-Aldrich Ltd., Dorset), and three 
types of TiO2; namely optisol® (Oxonica, Begbroke Science Park, Oxfordshire), Degussa P25 and 
T805 (Evonik Degussa, Germany), as per the grant. Additionally we tested CdS particles (donated 
by Paul Christian at Birmingham via CEFAS Weymouth). Tissue metal analysis is underway. 
  
The main outcome has been that during both in vivo and in vitro exposures we have seen little or 
no immunotoxicity caused by the metal NP even at high doses. The only impairment of immune 
activity was observed following exposures to ZnO NP, and the effects were much lower than those 
caused by matching concentrations of ZnCl2 (based on metal mass). These results support the 
growing body of evidence that toxicity of metal NP does not exceed that of their ionic form. 
We have met all the objectives set out in the grant, although the RAMAN work needs elaborating. 
  
Exposure validation: The aqueous and physiological saline solutions of the NP used for exposures 
were made up and stirred prior to use (but not sonicated). This was to obtain the most natural 
exposure conditions possible. Partical size distributions and aggregation were tested using the 
NanoSight and EM equipment, under the expert quidance kindly made available by Alison Crossley 
at Oxford University, Begbroke Science Park. For ZnO NP @ 35mg NP/l aggregates proved to be 
in the 150 – 300 nm range. For TiO2, the Degussa P25 NP @ 25 mg NP/l were mainly present as 5-
10 particle aggregates with very few small and large (>500 nm) aggregates. Degussa T805 NP @ 
17.5 mg NP/l proved very hydrophobic and had few particles <20 nm, some at 100-300nm, but was 
mostly present as 500nm aggregates. Oxonicas TiO2 Optisol® @ 7.8mg NP/l had particle sizes of 
around 10-100nm, but was mainly present as 250-400nm aggregates.  The Birmingham CdS NP 
were too small to be observed on the NanoSight, indicating that individual particles of 5nm do not 
aggregate to more than 20nm aggregates, and most likely are present as single particles. 
  
ZnO NP vs ZnCl2 in vivo: Initial in vivo exposures to ZnO NP vs. matched ZnCl2 showed no effect 
on immune activity of either Zn form up to the top dose of 12.5mg/l.  An in vivo exposure was then 
set up in soil using controls and two concentrations (viz. 250 & 750mg Zn/kg soil) of both ZnCl2 
and ZnO NP. After 21 days exposure to ZnCl2, somatic growth was reduced at 750mg Zn /kg soil 
while reproduction declined at both concentrations. Exposure to ZnO NP had no significant effect 
on growth and only reduced reproduction slightly at 750 mg Zn/kg soil. Immune activity was 
significantly lowered by both ZnCl2 treatments, while ZnO NP treatments had no detectable effect. 
  
TiO2 NP in vivo: No effects were observed on any parameter after exposures to Degussa P25 NP @ 
25 mg NP/l, Degussa T805 NP @ 17.5 mg NP/l, or Oxonicas TiO2 Optisol® @ 7.8mg NP/l. 
 
ZnO NP and TiO2 NP in vitro: 24 hour exposure of immune cells to TiO2 NP: P25 @ 12.5mg/l, 
T805 @ 8.75 mg/l & Optisol @ 3.9mg/l resulted in no effects on immune activity, while exposure 
to ZnO NP 35 mg/l caused a significant drop in immune active cells from 90% in the control to 
55% in the treated cells.  
 
CdS NP results: Comparing in vivo exposures to CdS NP and CdCl2 showed that survival was 
affected by CdCl2 concentrations above 2.5mg Cd/l with 100%  mortality occurring at 10mg Cd/l. 
In the CdS NP treatments however, there was no mortality at 20mg Cd/l. The CdCl2 exposures lead 
to reduced immune activity at concentrations as low as 3 mg Cd/l, while again there was no effect 
of 20 mg Cd/l CdS NP. Follow up in vitro exposures showed no effect of CdCl2 (0.625-10 mg Cd/l) 
nor CdS NP (1.25-20mg Cd/l) to immune activity and there was no masking effect on immune cell 
survival, indicting that only strong cells had survived to be assessed.  
